Drug Profile


Alternative Names: BA 7602-06; LOMUCIN; MSI 1995

Latest Information Update: 02 Sep 2014

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bago
  • Class Antiasthmatics; Antirheumatics; Benzofurans; Nonsteroidal anti-inflammatories; Pyridines; Small molecules
  • Mechanism of Action Mucin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Asthma; Cystic fibrosis; Gastrointestinal disorders

Most Recent Events

  • 28 May 2008 Talniflumate is available for licensing (http://www.genaera.com/business_development.php)
  • 05 Jul 2007 Discontinued - Phase-II for Cystic fibrosis in Ireland (PO)
  • 19 Apr 2005 No development reported - Phase-I for Asthma in Mexico (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top